1. Home >
  2. M&A >
  3. PIPE >
  4. United States >
  5. California >
  6. BVF Partners Invests In Eledon

Investment Summary

BVF Partners Invests In Eledon

On September 14, 2020, private equity firm BVF Partners invested in life science company Eledon

Investment Highlights
  • This is BVF Partners’ 2nd transaction in the Life Science sector.
  • This is BVF Partners’ 2nd transaction in the United States.
  • This is BVF Partners’ 1st transaction in California.

Investment Summary
Date 2020-09-14
Target Eledon
Sector Life Science
Investor(s) BVF Partners
Deal Type PIPE

Target

Eledon

Irvine, California, United States
Eledon is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Eledon is based in Irvine, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

BVF Partners

Category Private Equity Firm
Founded 1993
Size Small
Type Sector Focused
DESCRIPTION

BVF Partners LP is a private investment firm focused on providing long-term investments in small-cap public biotechnology companies. Prospective transaction types include management buyouts, recapitalizations, and venture. BVF Partners was formed in 1993 and is based in San Francisco, California.

DEAL STATS #
Overall 2 of 3
Sector: Life Science M&A 2 of 3
Type: PIPE M&A Deals 1 of 1
State: California M&A 1 of 2
Country: United States M&A 2 of 3
Year: 2020 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-13 SpringWorks Therapeutics

Stamford, Connecticut, United States

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. SpringWorks Therapeutics was founded in 2017 and is based in Stamford, Connecticut.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-16 Dren Bio

Foster City, California, United States

Dren Bio is a biotechnology company developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents. Dren’s lead programs are initially focused on hematologic neoplasms and solid cancers. Dren Bio was founded in 2019 and is based in Foster City, California.

Buy -
Mergr

Solution for

Product

Company

Legal